Similar articles

• [Comparative analysis of the effects to date of the prevention of Rh incompatibility].

  Jedwabny A, Suchocki S, Bobrowska G. Jedwabny A, et al. Acta Haematol Pol. 1988 Jan-Jun;19(1-2):56-8. Acta Haematol Pol. 1988. PMID: 2853507 Polish. No abstract available.
• [Prevention of fetal erythroblastosis with anti-D immunoglobulin].

  Rasteński J, Gryglicka M. Rasteński J, et al. Acta Haematol Pol. 1988 Jul-Dec;19(3-4):239-41. Acta Haematol Pol. 1988. PMID: 3150900 Polish. No abstract available.
• [Prevention of post-partum Rh-factor isoimmunization (experience of the Hospital 1st Gynecological-Obstetrical of the Mexican Institute of Social Security)].

  Cepeda AG, Sentíes L, Fiorelli FE, Garcete JA. Cepeda AG, et al. Ginecol Obstet Mex. 1975 Feb;37(220):83-91. Ginecol Obstet Mex. 1975. PMID: 804430 Spanish. No abstract available.
• [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].

  Spasova K, Vŭlcheva B. Spasova K, et al. Akush Ginekol (Sofiia). 1986;25(3):84-90. Akush Ginekol (Sofiia). 1986. PMID: 3019168 Review. Bulgarian. No abstract available.
• [Clinical aspects of prenatal prevention of rhesus incompatibility].

  Maas DH. Maas DH. Beitr Infusionsther. 1992;30:425-30. Beitr Infusionsther. 1992. PMID: 1284752 Review. German.